Wealth Enhancement Advisory Services LLC grew its position in CorVel Co. (NASDAQ:CRVL - Free Report) by 184.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,884 shares of the business services provider's stock after purchasing an additional 8,998 shares during the quarter. Wealth Enhancement Advisory Services LLC's holdings in CorVel were worth $1,545,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of the company. NorthCrest Asset Manangement LLC raised its position in shares of CorVel by 200.0% in the fourth quarter. NorthCrest Asset Manangement LLC now owns 8,235 shares of the business services provider's stock valued at $916,000 after purchasing an additional 5,490 shares during the period. Mackenzie Financial Corp bought a new position in CorVel during the fourth quarter worth $848,000. Kolinsky Wealth Management LLC increased its position in CorVel by 200.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 5,205 shares of the business services provider's stock worth $579,000 after acquiring an additional 3,470 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in CorVel by 234.5% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 93,606 shares of the business services provider's stock worth $10,415,000 after acquiring an additional 65,620 shares during the period. Finally, Voloridge Investment Management LLC increased its position in CorVel by 210.8% during the fourth quarter. Voloridge Investment Management LLC now owns 34,775 shares of the business services provider's stock worth $3,869,000 after acquiring an additional 23,585 shares during the period. Institutional investors own 51.36% of the company's stock.
Insiders Place Their Bets
In other CorVel news, Director R Judd Jessup sold 935 shares of CorVel stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $113.50, for a total transaction of $106,122.50. Following the sale, the director now owns 129,519 shares in the company, valued at $14,700,406.50. The trade was a 0.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, VP Jennifer Yoss sold 1,050 shares of CorVel stock in a transaction on Thursday, May 29th. The stock was sold at an average price of $111.39, for a total transaction of $116,959.50. Following the sale, the vice president now owns 2,088 shares in the company, valued at $232,582.32. This represents a 33.46% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 23,245 shares of company stock worth $2,690,457 over the last 90 days. Corporate insiders own 47.57% of the company's stock.
CorVel Price Performance
CRVL stock remained flat at $109.56 on Friday. 81,991 shares of the company were exchanged, compared to its average volume of 120,044. CorVel Co. has a fifty-two week low of $76.53 and a fifty-two week high of $128.61. The company has a 50 day simple moving average of $112.07 and a two-hundred day simple moving average of $116.23. The stock has a market capitalization of $5.63 billion, a price-to-earnings ratio of 64.45 and a beta of 1.02.
CorVel (NASDAQ:CRVL - Get Free Report) last announced its earnings results on Thursday, May 22nd. The business services provider reported $0.51 earnings per share (EPS) for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%. The business had revenue of $231.51 million for the quarter.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen raised shares of CorVel from a "hold" rating to a "buy" rating in a research report on Friday, April 18th.
Check Out Our Latest Report on CorVel
About CorVel
(
Free Report)
CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
Featured Articles

Before you consider CorVel, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CorVel wasn't on the list.
While CorVel currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.